Viruses, toxins, radiation or something else may cause MPDs.
Many people with MPDs wonder what causes these diseases. Some researchers believe that viral infections, exposure to toxins, exposure to radiation or something else may cause myeloproliferative disorders. Current research does not offer any proof. We just don’t know yet what causes these conditions.
We do know that many MPDs are related to a genetic mutation in a protein in our bodies called JAK2 – a protein which regulates blood cell production. Many people with MPDs show a mutation in this protein. A smaller number of people with MPDs have other, recently-discovered mutations. All these mutations occur in adulthood – in other words, people are not born with them but acquire them during their lives.
About 97% of people who have polycythaemia vera have the JAK2 V617F mutation, while just 50% of people with essential thrombocythaemia or myelofibrosis have the mutation.
We don’t know why some people who have an MPD have the mutation, and others don’t – but it may be that there are other mutations that occur earlier in the process of disease development, and that we haven’t discovered those mutations yet. The most recent research appears to indicate that the JAK2 mutation is a middle step in the development of myeloproliferative disease.
Something disconcerting for many people with these disorders is the sense that their MPD may have been caused by exposure to environmental toxins. While this is possible, there is no scientific evidence yet to prove whether this theory is correct or incorrect. Researchers are exploring whether “pockets” of PV patients exist. It appears that a number of people living in a small town in Pennsylvania (in the US) have all developed PV. Scientists want to understand if these people were exposed to environmental contaminants, notably from coal waste, that could have led them to develop PV. Detailed and reliable information on this issue and the efforts being made to understand is available from the United States Center for Disease Control Agency for Toxic Substances and Disease Registry website.
In very rare cases, myeloproliferative disorders can run in families. This is exceedingly rare, so it is generally not something most people with MPDs need to feel concerned about. Researchers in the United Kingdom and researchers at Harvard University and Brigham and Women’s Hospital in the US are researching genetic links in MPDs.
The US researchers are also specifically investigating whether people with Ashkenazi Jewish heritage are particularly susceptible to myeloproliferative disorders.
If you are aware of a first degree relative (parent, child, sibling) in your family with an MPD, please email us at info@mpdvoice.org.uk for more information or to learn more about the study.